Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility 
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions 
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility 
Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength 
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns 
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election 
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal 
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
SsangYong Motor Co. revealed last week it is now free from the debt rescheduling program as the Seoul Bankruptcy Court ruled there is no more obstacle to the execution of the company’s rehabilitation plan. The court made the decision since the South Korea-based automaker has already repaid most of the rehabilitation security rights and claims amounting to KRW351.7 billion or around $267 million.
"The company has paid all the debts owed to financial institutions as scheduled under its rehabilitation plan," the carmaker’s spokesperson said.
The court also said SsangYong Motor has around KRW290.7 billion in funds for its operation. The firm’s sales also improved after it introduced its new Torres SUV model this year.
Additionally, it also formed its new board of directors, which apparently has a positive impact on the company. With the good developments, the company managed to emerge from the court receivership after 19 months.
Korea Joongang Daily reported that the automobile manufacturer has been placed under court receivership since April of last year. This happened because SsangYong Motor’s parent company, Mahindra & Mahinda, was not able to find new investors as the business was on a decline after suffering from financial issues that were only getting worst amid the COVID-19 pandemic.
It was in August when the bankruptcy court approved the company’s debt payment plans. This was after the court chose the KG Group-led consortium as the final bidder for the acquisition of SsangYong Motor in June.
In the last decade, SsangYong Motor already went through two rounds of court receivership. In 2004, China’s SAIC Motor Corp., Ltd. purchased a 51% share in the company, but it gave up its control over SsangYong in 2009 at the heels of a financial crisis that was affecting businesses worldwide. Eventually, the company was placed under court receivership for the first time, as per Yonhap News Agency.
In 2011, India’s Mahindra & Mahindra automotive manufacturer invested KRW523 billion to purchase a 70% stake in SsangYong. Its stake ownership increased to 74.65%, but as of Sept. 28, KG Group has become the biggest stakeholder with 61.88%, while Mahindra now owns just 10.15%, with the remainder being owned by other investors.
